Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Kneat Recognised as Leader in G2 Pharma and Biotech Fall 2025 Grid Reports

By: Newsfile

Score based on User Satisfaction and Market Presence significantly exceeds peers

Limerick, Ireland--(Newsfile Corp. - September 24, 2025) - kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, has been awarded the top position in three of G2 Software Review's Fall 2025 Pharma and Biotech Software category reports. Kneat was recognized as:

Kneat achieved a total G2 Satisfaction Score of 98 out of 100, 20 points higher than the second-ranked company's score of 78.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/11876/267637_kneatimg1_550.jpg

Grid from Fall 2025 G2 Grid® Report for Pharma and Biotech

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11876/267637_kneatimg1.jpg

"Earning three G2 leader badges is no small feat for a software company supporting any industry, let alone one as demanding and precise as life sciences," said Eddie Ryan, CEO of Kneat. "The achievement reflects not only the trust that our customers place in us, but the dedication of our team to deliver Kneat's pioneering user-focused software. At Kneat, customer satisfaction isn't just a value — it's at the heart of everything we do. I am proud of our team for embracing this mission every single day."

Kneat's top rating in the G2 Pharma and Biotech Relationship Index is based on customer feedback across categories "Ease of Doing Business," "Likely to Recommend," and "Quality of Support." Kneat was also rated 2nd overall in the G2 Pharma and Biotech Usability Index measuring customer feedback on "Ease of Admin," "Ease of Use" and "Meets Requirements."

G2 scores are based on validated reviews from industry professionals utilising factors such as a company's review count, web presence, growth, influence and engagement. As the largest and most trusted software marketplace, G2 offers 100% validated reviews that more than a million professionals annually — including employees at all Fortune 500 companies — rely on to make informed decisions about their software purchases.

About Kneat

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. compliance standard. Independent customer studies have shown Kneat Gx to reduce labor hours associated with validation documentation by more than 50%, accelerate review and approval cycles by up to 50%, and consistently support higher standards of regulatory compliance. For more information visit www.kneat.com.

For further information:

Katie Keita, Kneat Investor Relations
P: + 1 902-450-2660
E: investors@kneat.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267637

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.